A slow launch for Alzheimer's medicine Leqembi, a lackluster pipeline and a challenging drug launch environment are just a ...

Multiple clinical trial milestones were achieved, including encouraging topline data for a Phase 2 trial in CCM, the first ...

A single biopsy from a metastatic breast cancer tumor contains hundreds of thousands of cells—some cancerous and others part ...

With climbing biotech M&A and IPO activity following the post-pandemic slump, experts offer insights on maximizing value and ...

Welcome to BioNTech's third quarter 2024 earnings call. I would like to hand the call over to Michael Horowicz Director, Investor Relations. Please go ahead.

Genentech applies that same science-driven ... while ensuring the benefits actually go to the patients who need them. Building coalitions on issues like that will help us solve a lot of the ...

Q3 2024 Earnings Call Transcript October 29, 2024 Nautilus Biotechnology, Inc. beats earnings expectations. Reported EPS is $ ...

Breast Cancer: The FDA approved inavolisib, marketed by Genentech as Itovebi ... is working to increase access to HIV medications by building and managing in-house pharmacies for community ...

Dr. Gibson has led a number of key partnerships for Recursion with leading pharma and tech companies, including Roche/Genentech ... About Cellino Cellino is building an ultra-scalable, autonomous ...

Anu Codaty, VP of global marketing and strategy at Aldevron, is blazing trails in biotech, inspired by a family legacy in ...

Operator Good morning and good afternoon, and welcome to the Novartis Q3 2024 results release conference call and live ...

We demonstrated one, a scalable and reliable process for building flow cells and chips ... were initiated as part of our partnership with Genentech, and represent a general template for what ...